The global Fibromyalgia Drugs market was valued at US$ 2862.4 million in 2023 and is anticipated to reach US$ 3239.1 million by 2030, witnessing a CAGR of 1.8% during the forecast period 2024-2030.

Fibromyalgia Drugs Market

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.

The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.

This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Drugs.

Report Scope

The Fibromyalgia Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fibromyalgia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fibromyalgia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fibromyalgia Drugs Market Report

Report Metric	Details
Report Name	Fibromyalgia Drugs Market
Accounted market size in 2023	US$ 2862.4 million
Forecasted market size in 2030	US$ 3239.1 million
CAGR	1.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Serotonin Norepinephrine Reuptake Inhibitors GABA Analogs Other
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibromyalgia Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Fibromyalgia Drugs Market growing?

Ans: The Fibromyalgia Drugs Market witnessing a CAGR of 1.8% during the forecast period 2024-2030.

What is the Fibromyalgia Drugs Market size in 2030?

Ans: The Fibromyalgia Drugs Market size in 2030 will be US$ 3239.1 million.

Who are the main players in the Fibromyalgia Drugs Market report?

Ans: The main players in the Fibromyalgia Drugs Market are Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP)

What are the Application segmentation covered in the Fibromyalgia Drugs Market report?

Ans: The Applications covered in the Fibromyalgia Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Fibromyalgia Drugs Market report?

Ans: The Types covered in the Fibromyalgia Drugs Market report are Serotonin Norepinephrine Reuptake Inhibitors, GABA Analogs, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fibromyalgia Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Serotonin Norepinephrine Reuptake Inhibitors

1.2.3 GABA Analogs

1.2.4 Other

1.3 Market by Application

1.3.1 Global Fibromyalgia Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fibromyalgia Drugs Market Perspective (2019-2030)

2.2 Fibromyalgia Drugs Growth Trends by Region

2.2.1 Global Fibromyalgia Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Fibromyalgia Drugs Historic Market Size by Region (2019-2024)

2.2.3 Fibromyalgia Drugs Forecasted Market Size by Region (2025-2030)

2.3 Fibromyalgia Drugs Market Dynamics

2.3.1 Fibromyalgia Drugs Industry Trends

2.3.2 Fibromyalgia Drugs Market Drivers

2.3.3 Fibromyalgia Drugs Market Challenges

2.3.4 Fibromyalgia Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fibromyalgia Drugs Players by Revenue

3.1.1 Global Top Fibromyalgia Drugs Players by Revenue (2019-2024)

3.1.2 Global Fibromyalgia Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Fibromyalgia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Fibromyalgia Drugs Revenue

3.4 Global Fibromyalgia Drugs Market Concentration Ratio

3.4.1 Global Fibromyalgia Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Drugs Revenue in 2023

3.5 Fibromyalgia Drugs Key Players Head office and Area Served

3.6 Key Players Fibromyalgia Drugs Product Solution and Service

3.7 Date of Enter into Fibromyalgia Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Drugs Breakdown Data by Type

4.1 Global Fibromyalgia Drugs Historic Market Size by Type (2019-2024)

4.2 Global Fibromyalgia Drugs Forecasted Market Size by Type (2025-2030)

5 Fibromyalgia Drugs Breakdown Data by Application

5.1 Global Fibromyalgia Drugs Historic Market Size by Application (2019-2024)

5.2 Global Fibromyalgia Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Fibromyalgia Drugs Market Size (2019-2030)

6.2 North America Fibromyalgia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Fibromyalgia Drugs Market Size by Country (2019-2024)

6.4 North America Fibromyalgia Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fibromyalgia Drugs Market Size (2019-2030)

7.2 Europe Fibromyalgia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Fibromyalgia Drugs Market Size by Country (2019-2024)

7.4 Europe Fibromyalgia Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fibromyalgia Drugs Market Size (2019-2030)

8.2 Asia-Pacific Fibromyalgia Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fibromyalgia Drugs Market Size (2019-2030)

9.2 Latin America Fibromyalgia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Fibromyalgia Drugs Market Size by Country (2019-2024)

9.4 Latin America Fibromyalgia Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fibromyalgia Drugs Market Size (2019-2030)

10.2 Middle East & Africa Fibromyalgia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Fibromyalgia Drugs Introduction

11.1.4 Pfizer Revenue in Fibromyalgia Drugs Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Detail

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Fibromyalgia Drugs Introduction

11.2.4 Eli Lilly Revenue in Fibromyalgia Drugs Business (2019-2024)

11.2.5 Eli Lilly Recent Development

11.3 Actavis

11.3.1 Actavis Company Detail

11.3.2 Actavis Business Overview

11.3.3 Actavis Fibromyalgia Drugs Introduction

11.3.4 Actavis Revenue in Fibromyalgia Drugs Business (2019-2024)

11.3.5 Actavis Recent Development

11.4 Merck Sharp and Dohme

11.4.1 Merck Sharp and Dohme Company Detail

11.4.2 Merck Sharp and Dohme Business Overview

11.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Introduction

11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2019-2024)

11.4.5 Merck Sharp and Dohme Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Detail

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Fibromyalgia Drugs Introduction

11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2019-2024)

11.5.5 Daiichi Sankyo Recent Development

11.6 Innovative Med Concepts

11.6.1 Innovative Med Concepts Company Detail

11.6.2 Innovative Med Concepts Business Overview

11.6.3 Innovative Med Concepts Fibromyalgia Drugs Introduction

11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2019-2024)

11.6.5 Innovative Med Concepts Recent Development

11.7 Meda

11.7.1 Meda Company Detail

11.7.2 Meda Business Overview

11.7.3 Meda Fibromyalgia Drugs Introduction

11.7.4 Meda Revenue in Fibromyalgia Drugs Business (2019-2024)

11.7.5 Meda Recent Development

11.8 Meiji Seika

11.8.1 Meiji Seika Company Detail

11.8.2 Meiji Seika Business Overview

11.8.3 Meiji Seika Fibromyalgia Drugs Introduction

11.8.4 Meiji Seika Revenue in Fibromyalgia Drugs Business (2019-2024)

11.8.5 Meiji Seika Recent Development

11.9 Switch Biotech

11.9.1 Switch Biotech Company Detail

11.9.2 Switch Biotech Business Overview

11.9.3 Switch Biotech Fibromyalgia Drugs Introduction

11.9.4 Switch Biotech Revenue in Fibromyalgia Drugs Business (2019-2024)

11.9.5 Switch Biotech Recent Development

11.10 Theravance

11.10.1 Theravance Company Detail

11.10.2 Theravance Business Overview

11.10.3 Theravance Fibromyalgia Drugs Introduction

11.10.4 Theravance Revenue in Fibromyalgia Drugs Business (2019-2024)

11.10.5 Theravance Recent Development

11.11 Zynerba Pharmaceuticals

11.11.1 Zynerba Pharmaceuticals Company Detail

11.11.2 Zynerba Pharmaceuticals Business Overview

11.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Introduction

11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2019-2024)

11.11.5 Zynerba Pharmaceuticals Recent Development

11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)

11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Detail

11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Introduction

11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2019-2024)

11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Eli Lilly

Actavis

Merck Sharp and Dohme

Daiichi Sankyo

Innovative Med Concepts

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

List of Tables

Table 1. Global Fibromyalgia Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Serotonin Norepinephrine Reuptake Inhibitors

Table 3. Key Players of GABA Analogs

Table 4. Key Players of Other

Table 5. Global Fibromyalgia Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Fibromyalgia Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Fibromyalgia Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Fibromyalgia Drugs Market Share by Region (2019-2024)

Table 9. Global Fibromyalgia Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Fibromyalgia Drugs Market Share by Region (2025-2030)

Table 11. Fibromyalgia Drugs Market Trends

Table 12. Fibromyalgia Drugs Market Drivers

Table 13. Fibromyalgia Drugs Market Challenges

Table 14. Fibromyalgia Drugs Market Restraints

Table 15. Global Fibromyalgia Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Fibromyalgia Drugs Market Share by Players (2019-2024)

Table 17. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2023)

Table 18. Ranking of Global Top Fibromyalgia Drugs Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Fibromyalgia Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Fibromyalgia Drugs Product Solution and Service

Table 22. Date of Enter into Fibromyalgia Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Fibromyalgia Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Fibromyalgia Drugs Revenue Market Share by Type (2019-2024)

Table 26. Global Fibromyalgia Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Fibromyalgia Drugs Revenue Market Share by Type (2025-2030)

Table 28. Global Fibromyalgia Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Fibromyalgia Drugs Revenue Market Share by Application (2019-2024)

Table 30. Global Fibromyalgia Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Fibromyalgia Drugs Revenue Market Share by Application (2025-2030)

Table 32. North America Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Fibromyalgia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Fibromyalgia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Fibromyalgia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Fibromyalgia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Fibromyalgia Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Fibromyalgia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Fibromyalgia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Pfizer Company Detail

Table 48. Pfizer Business Overview

Table 49. Pfizer Fibromyalgia Drugs Product

Table 50. Pfizer Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Eli Lilly Company Detail

Table 53. Eli Lilly Business Overview

Table 54. Eli Lilly Fibromyalgia Drugs Product

Table 55. Eli Lilly Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 56. Eli Lilly Recent Development

Table 57. Actavis Company Detail

Table 58. Actavis Business Overview

Table 59. Actavis Fibromyalgia Drugs Product

Table 60. Actavis Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 61. Actavis Recent Development

Table 62. Merck Sharp and Dohme Company Detail

Table 63. Merck Sharp and Dohme Business Overview

Table 64. Merck Sharp and Dohme Fibromyalgia Drugs Product

Table 65. Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 66. Merck Sharp and Dohme Recent Development

Table 67. Daiichi Sankyo Company Detail

Table 68. Daiichi Sankyo Business Overview

Table 69. Daiichi Sankyo Fibromyalgia Drugs Product

Table 70. Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 71. Daiichi Sankyo Recent Development

Table 72. Innovative Med Concepts Company Detail

Table 73. Innovative Med Concepts Business Overview

Table 74. Innovative Med Concepts Fibromyalgia Drugs Product

Table 75. Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 76. Innovative Med Concepts Recent Development

Table 77. Meda Company Detail

Table 78. Meda Business Overview

Table 79. Meda Fibromyalgia Drugs Product

Table 80. Meda Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 81. Meda Recent Development

Table 82. Meiji Seika Company Detail

Table 83. Meiji Seika Business Overview

Table 84. Meiji Seika Fibromyalgia Drugs Product

Table 85. Meiji Seika Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 86. Meiji Seika Recent Development

Table 87. Switch Biotech Company Detail

Table 88. Switch Biotech Business Overview

Table 89. Switch Biotech Fibromyalgia Drugs Product

Table 90. Switch Biotech Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 91. Switch Biotech Recent Development

Table 92. Theravance Company Detail

Table 93. Theravance Business Overview

Table 94. Theravance Fibromyalgia Drugs Product

Table 95. Theravance Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 96. Theravance Recent Development

Table 97. Zynerba Pharmaceuticals Company Detail

Table 98. Zynerba Pharmaceuticals Business Overview

Table 99. Zynerba Pharmaceuticals Fibromyalgia Drugs Product

Table 100. Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 101. Zynerba Pharmaceuticals Recent Development

Table 102. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Detail

Table 103. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product

Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2019-2024) & (US$ Million)

Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Fibromyalgia Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Fibromyalgia Drugs Market Share by Type: 2023 VS 2030

Figure 3. Serotonin Norepinephrine Reuptake Inhibitors Features

Figure 4. GABA Analogs Features

Figure 5. Other Features

Figure 6. Global Fibromyalgia Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Fibromyalgia Drugs Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Other Case Studies

Figure 11. Fibromyalgia Drugs Report Years Considered

Figure 12. Global Fibromyalgia Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Fibromyalgia Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Fibromyalgia Drugs Market Share by Region: 2023 VS 2030

Figure 15. Global Fibromyalgia Drugs Market Share by Players in 2023

Figure 16. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Fibromyalgia Drugs Revenue in 2023

Figure 18. North America Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Fibromyalgia Drugs Market Share by Country (2019-2030)

Figure 20. United States Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Fibromyalgia Drugs Market Share by Country (2019-2030)

Figure 24. Germany Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Fibromyalgia Drugs Market Share by Region (2019-2030)

Figure 32. China Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Fibromyalgia Drugs Market Share by Country (2019-2030)

Figure 40. Mexico Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Fibromyalgia Drugs Market Share by Country (2019-2030)

Figure 44. Turkey Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Fibromyalgia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pfizer Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 47. Eli Lilly Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 48. Actavis Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 49. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 50. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 51. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 52. Meda Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 53. Meiji Seika Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 54. Switch Biotech Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 55. Theravance Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 56. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 57. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Drugs Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions